Name | Number of supported studies | Average coverage | |
---|---|---|---|
ciliated cell | 7 studies | 28% ± 12% | |
natural killer cell | 7 studies | 25% ± 15% | |
oligodendrocyte precursor cell | 5 studies | 27% ± 8% | |
CD16-negative, CD56-bright natural killer cell, human | 4 studies | 19% ± 3% | |
epithelial cell | 4 studies | 30% ± 13% | |
type I pneumocyte | 3 studies | 26% ± 13% | |
goblet cell | 3 studies | 17% ± 0% |
Insufficient scRNA-seq data for expression of B3GNT7 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 99% | 2754.51 | 179 / 180 | 95% | 28.57 | 409 / 430 |
pancreas | 100% | 1384.76 | 328 / 328 | 89% | 54.51 | 159 / 178 |
lung | 100% | 2577.20 | 578 / 578 | 86% | 54.32 | 998 / 1155 |
stomach | 96% | 2115.89 | 345 / 359 | 82% | 48.96 | 234 / 286 |
adrenal gland | 100% | 2108.53 | 258 / 258 | 77% | 47.52 | 178 / 230 |
thymus | 93% | 443.83 | 605 / 653 | 83% | 22.70 | 503 / 605 |
intestine | 97% | 2841.30 | 933 / 966 | 76% | 45.87 | 399 / 527 |
esophagus | 71% | 263.84 | 1026 / 1445 | 80% | 56.39 | 146 / 183 |
uterus | 86% | 367.71 | 146 / 170 | 54% | 13.00 | 247 / 459 |
bladder | 67% | 168.05 | 14 / 21 | 55% | 16.56 | 275 / 504 |
brain | 90% | 495.81 | 2372 / 2642 | 28% | 5.23 | 195 / 705 |
kidney | 83% | 270.18 | 74 / 89 | 18% | 1.97 | 160 / 901 |
spleen | 100% | 864.40 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 22.15 | 1 / 1 |
breast | 62% | 200.19 | 283 / 459 | 29% | 6.05 | 319 / 1118 |
prostate | 78% | 256.96 | 191 / 245 | 11% | 0.93 | 56 / 502 |
skin | 18% | 42.48 | 328 / 1809 | 62% | 18.81 | 292 / 472 |
blood vessel | 78% | 438.30 | 1040 / 1335 | 0% | 0 | 0 / 0 |
heart | 69% | 359.75 | 595 / 861 | 0% | 0 | 0 / 0 |
adipose | 66% | 310.36 | 790 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 59% | 7.81 | 17 / 29 |
peripheral blood | 58% | 754.55 | 537 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 57% | 7.64 | 46 / 80 |
tonsil | 0% | 0 | 0 / 0 | 49% | 5.66 | 22 / 45 |
liver | 12% | 29.50 | 27 / 226 | 14% | 5.51 | 56 / 406 |
muscle | 0% | 0.21 | 1 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0016266 | Biological process | O-glycan processing |
GO_0030311 | Biological process | poly-N-acetyllactosamine biosynthetic process |
GO_0006493 | Biological process | protein O-linked glycosylation |
GO_0018146 | Biological process | keratan sulfate biosynthetic process |
GO_0000139 | Cellular component | Golgi membrane |
GO_0008375 | Molecular function | acetylglucosaminyltransferase activity |
GO_0008194 | Molecular function | UDP-glycosyltransferase activity |
GO_0008499 | Molecular function | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity |
GO_0005515 | Molecular function | protein binding |
GO_0008532 | Molecular function | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity |
Gene name | B3GNT7 |
Protein name | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7 (BGnT-7) (Beta-1,3-Gn-T7) (Beta-1,3-N-acetylglucosaminyltransferase 7) (Beta3Gn-T7) (EC 2.4.1.-) |
Synonyms | |
Description | FUNCTION: N-acetyl glucosamine (GlcNAc) transferase that catalyzes the transfer of GlcNAc via a beta1->3 linkage from UDP-GlcNAc to the non-reducing terminal galactose (Gal) in the linearly growing chain of N- and O-linked keratan sulfate proteoglycans. Cooperates with B4GALT4 galactosyltransferase and CHST6 and CHST1 sulfotransferases to construct and elongate mono- and disulfated disaccharide units [->3Galbeta1->4(6-sulfoGlcNAcbeta)1->] and [->3(6-sulfoGalbeta)1->4(6-sulfoGlcNAcbeta)1->] within keratan sulfate polymer . Involved in biosynthesis of N-linked keratan sulfate proteoglycans in cornea, with an impact on proteoglycan fibril organization and corneal transparency (By similarity). May play a role in the maintenance of tissue architecture by suppressing cellular motility and invasion (By similarity). . |
Accessions | ENST00000287590.6 Q8NFL0 |